PrimeRFP SCOUT · Federal Contract Recompete Brief

15B10225F00000006Fy25 b1 mckesson MEDS OCT 24 — Mckesson Corp

Mckesson Corp holds $32.0B across 6,790 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36W79720D0001. PoP ended Feb 17, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fci Ashland
Awarding office
Mckesson Corp
Recipient
Feb 17, 2025
PoP end
$95K
Obligated
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Mckesson Corp — $90

Contract facts

Federal
Contract number15B10225F00000006
Also listed as36W79720D0001-15B10225F00000006
AgencyFci Ashland
Awarding officeFci Ashland
IncumbentMckesson Corp
UEIS1RUKWWRYFL6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36W79720D0001
Place of performanceIRVING, TX
PoP end (current)Feb 17, 2025
Obligated$95K

FY25 B1 MCKESSON MEDS OCT 24 is a federal award for Fci Ashland held by Mckesson Corp. Estimated value $514.7M ($95K obligated). Current period of performance ends Feb 17, 2025. Place of performance: IRVING, TX.

Recompete timing

Public
Past PoP end (549 days ago)

Current PoP ended Feb 17, 2025 (549 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Mckesson Corp$32.0B obligated across 6,790 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($32.0B) · all agencies
Department of Veterans Affairs (VA)$30.8B · 96%Department of Justice (DOJ)$617.6M · 2%Department of Health and Human Services (HHS)$535.6M · 2%Department of Homeland Security (DHS)$9.3M · 0%
Open full company profile

Related awards

Same parent · incumbent
75H71025F26077
PHARMACEUTICAL SUPPLIES FOR TOHATCHI HEALTH CENTER
$127K
Aug 22, 2026
75H71225F28067
BPA CALL AGAINST MCKESSON IHS BPA # 75H71122A00161 FOR OPEN MARKET PHARMACEUTICAL PRODUCTS…
$249K
Aug 23, 2026
15B30226F00000093
MCKESSON REGULAR MEDICATION AUGUST 2026 FISCAL YEAR 2026 RP#: 0167-26
$600K
Aug 31, 2026
15B31426F00000053
B1- FY26 MCKESSON CONTRACT MEDICATION
$495K
Aug 31, 2026
15B41426F00000265
FY26 B1 MCKESSON B12648613F MEDS AUG 26
$275K
Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 15B10225F00000006?

15B10225F00000006 (Fy25 b1 mckesson MEDS OCT 24) is a Fci Ashland award with an estimated value of $514.7M, currently held by Mckesson Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15B10225F00000006?

Fci Ashland awarded 15B10225F00000006 to Mckesson Corp.

Who is the incumbent on 15B10225F00000006?

Mckesson Corp is the incumbent with $32.0B across 6790 related awards in SCOUT’s public footprint. The current period of performance ends Feb 17, 2025.

When does Mckesson Corp’s 15B10225F00000006 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 17, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/15B10225F00000006